# NeuroSense Therapeutics Ltd. (NRSN)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NRSN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -4.82M | $ -2.0K | $ 170.0K | $ -1.56M |
| 2024 | $ 0 | $ -10.73M | $ 0 | $ 73.0K | $ 2.58M |
| 2023 | $ 0 | $ -11.15M | $ 0 | $ 142.0K | $ -1.76M |
| 2022 | $ 0 | $ -13.79M | $ 0 | $ 211.0K | $ 5.62M |
| 2021 | $ 0 | $ -4.80M | $ 0 | $ 0 | $ 9.01M |
| 2020 | $ 0 | $ -3.60M | $ -894 | $ 0 | $ 659.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.11 |
| Liabilities / Eq | -1.66 |
| Current Ratio | 0.31 |

## Other views

- [Metrics](https://sponda.capital/en/NRSN.md)
- [Charts](https://sponda.capital/en/NRSN/charts.md)
- [Compare](https://sponda.capital/en/NRSN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.